Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_assertion type Assertion NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_head.
- NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_assertion description "[Ecallantide is a potent and specific plasma kallikrein inhibitor approved for the treatment of acute attacks of HAE affecting any anatomic site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_provenance.
- NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_assertion evidence source_evidence_literature NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_provenance.
- NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_assertion SIO_000772 22149337 NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_provenance.
- NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_assertion wasDerivedFrom befree-20150227 NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_provenance.
- NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_assertion wasGeneratedBy ECO_0000203 NP526418.RAf-3iWBasdR8NBwQmMYkxF8FduuQrg_p5WZmthgcCu4Q130_provenance.